What is the primary goal of non-surgical Phase I therapy?

What is the primary goal of non-surgical Phase I therapy?

• A. Reduce inflammation only
• B. Eliminate plaque, calculus, and altered cementum
• C. Promote bone regeneration
• D. Eliminate periodontal pockets

Answer: (B)

The primary goal of non-surgical Phase I therapy is to eliminate plaque, calculus, and altered cementum. This phase focuses on comprehensive periodontal debridement to remove biofilm and calcified deposits, which are critical in the progression of periodontal disease. By effectively managing these factors, the therapy aims to restore gingival health, minimize inflammation, and create an environment conducive to healing. Following this initial phase, if periodontal health is achieved, the need for further surgical intervention may be mitigated. Non-surgical Phase I therapy is crucial because it treats the underlying causes of periodontal disease, promoting the potential for successful outcomes in maintaining periodontal health. This approach is not only about reducing inflammation, although that is a significant benefit; rather, it encompasses a broader goal of addressing the biological factors contributing to periodontal disease comprehensively.

The primary goal of non-surgical Phase I therapy is to eliminate plaque, calculus, and altered cementum. This phase focuses on comprehensive periodontal debridement to remove biofilm and calcified deposits, which are critical in the progression of periodontal disease. By effectively managing these factors, the therapy aims to restore gingival health, minimize inflammation, and create an environment conducive to healing.

Following this initial phase, if periodontal health is achieved, the need for further surgical intervention may be mitigated. Non-surgical Phase I therapy is crucial because it treats the underlying causes of periodontal disease, promoting the potential for successful outcomes in maintaining periodontal health. This approach is not only about reducing inflammation, although that is a significant benefit; rather, it encompasses a broader goal of addressing the biological factors contributing to periodontal disease comprehensively.